July 29, 2013

CAS databases provide millions of journal article references from more than 10,000 major scientific journals worldwide, patent and patent family references from 63 patent authorities around the world, and other reputable web sources.

The following patent record is from the CAplusSM database.

CAPLUS COPYRIGHT 2013 ACS

Patent Number: WO 2013063214
Title: Preparation of pyrazolo[4,3-c]pyridines as ERK inhibitors for cancer treatment
Inventor(s):

Lim, Jongwon; Kelley, Elizabeth Helen; Methot, Joey L.; Zhou, Hua; Petrocchi, Alessia; Mansoor, Umar Faruk; Fischer, Christian; O'Boyle, Brendan M.; Guerin, David Joseph; Bienstock, Corey E.; Boyce, Christopher W.; Daniels, Matthew H.; Falcone, Danielle; Ferguson, Ronald D., II; Fevrier, Salem; Huang, Xianhai; Lipford, Kathryn Ann; Sloman, David L.; Wilson, Kevin; Zhou, Wei; Witter, David; Maletic, Milana M.; Siliphaivanh, Phieng

Patent Assignee(s): Merck Sharp & Dohme Corp., USA
Source: PCT Int. Appl., 323pp. CODEN: PIXXD2
Language: English

Abstract:
Disclosed are the ERK inhibitors of formula I (wherein X is S or O; R1 is H, halo, CN, (un)substituted heteroaryl, etc.; R2 is H, (C1-6)alkyl, (un)substituted aryl, etc.; R3 is H, (C1-6)alkyl, (un)substituted aryl, etc.; R4 is H, halo, (C1-C6)alkyl, OH and NH2) and the pharmaceutically acceptable salts thereof.  Also disclosed are methods of treating cancer using the compds. of formula I an of synthesizing compds. of formula I. Example compd. II was prepd. from intermediate III and 1-(tert-butoxycarbonyl)piperidine-3-carboxylic acid in the presence of diphenylphosphoryl azide and TEA.  In an active mouse ERK2 activity assay, II had an IC50 of 3.13 nM.

Please note:  Abstracts and Titles for patent records in CAplus are routinely enhanced to better describe the claimed invention.

 View the full-text here.

Recent News


    June 29, 2015 | CAS Assigns the 100 Millionth CAS
    Registry Number to a Substance Designed to
    Treat Acute Myeloid Leukemia
   
    March 17, 2015 | New Content Provides Regulatory
    Professionals with Additional Value

    February 9, 2015 | Major New STN Release Delivers
    Essential Biomedical and Patent Content to IP
    Professionals

                                                                       More News >> 
 
 

Media Contact

 Name: Rhonda Ross
 Phone: 614-447-3624
 Email: cas-pr@cas.org